Last year, 24 cities and one county challenged the state’s top cannabis regulator for approving cannabis delivery in jurisdictions that banned cannabis businesses.
Epidiolex contains cannabidiol, or CBD, extracted from cannabis plants, and was first approved to treat severe forms of epilepsy.
The protections range from expanding banking access to preventing federal interference in states with legal cannabis, but passage in the Senate is uncertain.
Two meetings this summer will focus on recently-passed legislation that aims to expand equity in the cannabis industry.
The nation’s leaders have agreed to draw up adult-use legislation and set a date to vote on it.
The Food and Drug Administration drafted its long-awaited CBD policy, and sent it to the White House Office of Management and Budget for approval, a final step before publication.
An excerpt from recent editions of the Cannabis Wire Daily newsletter.
One of the world’s largest cannabis companies is now lobbying in at least a half dozen states.
Cannabis Wire has found that major cannabis companies, like Canopy Growth, are registered to lobby.